Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 19;17(4):712.
doi: 10.3390/cancers17040712.

Outcome of T2 Glottic Cancer Treated with Radiotherapy Alone or Concurrent Chemo-Radiotherapy

Po-Ying Peng  1 , Chien-Yu Lin  1 , Chun-Ta Liao  2 , Hung-Ming Wang  3 , Shiang-Fu Huang  2 , Yao-Te Tsai  4 , Chang-Hsien Lu  5 , Fu-Min Fang  6 , Meng-Hung Lin  7 , Miao-Fen Chen  1 , Wen-Cheng Chen  8
Affiliations

Outcome of T2 Glottic Cancer Treated with Radiotherapy Alone or Concurrent Chemo-Radiotherapy

Po-Ying Peng et al. Cancers (Basel). .

Abstract

Laryngeal cancer accounts for 10% of head and neck cancers, with glottic cancers comprising two-thirds of cases in our country [...].

Keywords: T2; chemo-radiotherapy; glottic carcinoma; outcomes; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest that could potentially influence the presentation or interpretation of the research findings in this study.

Figures

Figure 1
Figure 1
Kaplan–Meier plots of loco-regional recurrences (A), recurrence free survivals (B) and overall survivals (C) for patients who underwent concurrent chemoradiotherapy (CCRT) versus radiotherapy alone (RT).
Figure 2
Figure 2
Kaplan–Meier plots of loco-regional recurrences, recurrence free survivals and overall survivals for patients with subglottic extension (A–C) and impaired cord mobility (D–F) who underwent concurrent chemoradiotherapy (CCRT) versus radiotherapy alone (RT).
See this image and copyright information in PMC

References

    1. Ministry of Health and Welfare Cancer Registry Annual Report, 2022, Taiwan. [(accessed on 19 December 2024)]; Available online: https://www.hpa.gov.tw/File/Attach/18683/File_25342.pdf.
    1. Ogol’tsova E.S., Paches A.I., Matiakin E.G., Dvoírin V.V., Fedotenko S.P., Alferov V.S., Boikov V.P., Alekseeva S.I., Ol’shanskii V.O., Stiop L.D. Comparative evaluation of the effectiveness of radiotherapy, surgery and combined treatment of stage I-II laryngeal cancer (T1-2NoMo) based on the data of a cooperative randomized study. Vestn. Otorinolaringol. 1990;3:3–7. - PubMed
    1. Mendenhall W.M., Werning J.W., Hinerman R.W., Amdur R.J., Villaret D.B. Management of T1-T2 glottic carcinomas. Cancer. 2004;100:1786–1792. doi: 10.1002/cncr.20181. - DOI - PubMed
    1. Guimarães A.V., Dedivitis R.A., Matos L.L., Aires F.T., Cernea C.R. Comparison between transoral laser surgery and radiotherapy in the treatment of early glottic cancer: A systematic review and meta-analysis. Sci. Rep. 2018;8:11900. doi: 10.1038/s41598-018-30218-x. - DOI - PMC - PubMed
    1. Kadish S.P. Can I treat this small larynx lesion with radiation alone? Update on the radiation management of early (T1 and T2) glottic cancer. Otolaryngol. Clin. N. Am. 2005;38:1–9. doi: 10.1016/j.otc.2004.10.015. - DOI - PubMed

LinkOut - more resources